跳至主要内容
临床试验/JPRN-jRCTs043190014
JPRN-jRCTs043190014已完成2 期

Intradiscal injection therapy of platelet-rich plasma (PRP) - releasate for the patients with discogenic low back pain: Randomized control study - IDTPRCS

Akeda Koji0 个研究点目标入组 16 人开始时间: 2019年4月10日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
16

研究概览

简要总结

The intradiscal injection of PRPr showed clinically significant improvements in LBP intensity (more than 30% reduction) in patients with discogenic LBP, similar to those injected with glucocorticoid at eight weeks post-injection. PRPr treatment was safe and maintained improvements in pain, disability, and QOL during 60 weeks follow-up.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • Having low back pain more than three month
  • Visual analogue scare (VAS): more than 40% at baseline
  • ODI: more than 40% at bassline
  • Disc degeneration evaluated by MRI (more than grade II by Pfirrmann grading) from L3/4 to L4/5 lumbar disc
  • Less than 50% decrease of disc height measurement by lumbar radiograph
  • Discogenic pain evaluated by provocative discography
  • Written informed consent is obtained from the participant of this study

排除标准

  • Having remarkable cauda equine and neuropathy symptom
  • Having systematic or spinal infection
  • Past-history of lumbar surgeries
  • Past-history of interventional intervertebral disc therapy
  • Having intervertebral instability evaluated by lumbar radiograph
  • Patients having spondylolisthesis (more than grade I by Meyerding classification)
  • Having neuro-muscular diseases, cerebral diseases, malignant tumor and blood coagulation disorders
  • High risk for infectious diseases after the treatment
  • Having anti-coagulant drugs at the time of treatment
  • Pregnant patient
  • Difficulty in participating throughout the evaluation period
  • More than 10-points of BS-POS questionnaire test
  • Contraindication for MRI
  • Inappropriate patient for clinical study evaluate by doctors

研究者

发起方
Akeda Koji

相似试验